Dar Zavain

Recursion Pharmaceuticals, Inc. · Director

Dar Zavain is listed in filings as Director at Recursion Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jul 2, 2026, including 1 public disclosure. Recent filings connect the profile to Recursion Pharmaceuticals, Inc. (RXRX). The current snapshot covers public activity from Jul 2, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceCurrent Price
No direct insider buys or sells are available yet.